188 related articles for article (PubMed ID: 27368115)
1. Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.
Chuang JC; Shrager JB; Wakelee HA; Neal JW
Clin Ther; 2016 Jul; 38(7):1567-76. PubMed ID: 27368115
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
[TBL] [Abstract][Full Text] [Related]
3. Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras.
Takamochi K; Oh S; Matsuoka J; Suzuki K
Lung Cancer; 2012 Mar; 75(3):313-20. PubMed ID: 22209037
[TBL] [Abstract][Full Text] [Related]
4. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
[TBL] [Abstract][Full Text] [Related]
5. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
[TBL] [Abstract][Full Text] [Related]
6. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
Zhong WZ; Wu YL; Yang XN; Guo AL; Su J; Zhang XC; Luo DL; Wang Z; Chen HJ; Zhou Q; Xu CR; Qiao GB; Liao RQ; Yang JJ; Mok TS
Clin Lung Cancer; 2010 May; 11(3):160-8. PubMed ID: 20439191
[TBL] [Abstract][Full Text] [Related]
7. Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.
Bonanno L; Calabrese F; Nardo G; Calistri D; Tebaldi M; Tedaldi G; Polo V; Vuljan S; Favaretto A; Conte P; Amadori A; Rea F; Indraccolo S
Lung Cancer; 2016 Jun; 96():52-5. PubMed ID: 27133750
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
[TBL] [Abstract][Full Text] [Related]
9. Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.
Villa C; Cagle PT; Johnson M; Patel JD; Yeldandi AV; Raj R; DeCamp MM; Raparia K
Arch Pathol Lab Med; 2014 Oct; 138(10):1353-7. PubMed ID: 24571650
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: a case report.
Jin B; Zhang S; Chuang X; Yu P; Chen Y; Teng Y; Che X; Fan Y; Zheng C; Li X; Qiu X; Qu X; Liu Y
BMC Cancer; 2018 Nov; 18(1):1138. PubMed ID: 30453894
[TBL] [Abstract][Full Text] [Related]
11. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.
Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ
Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655
[TBL] [Abstract][Full Text] [Related]
12. Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities.
Liu M; He WX; Song N; Yang Y; Zhang P; Jiang GN
Eur J Cardiothorac Surg; 2016 Nov; 50(5):909-913. PubMed ID: 27032467
[TBL] [Abstract][Full Text] [Related]
13. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
Rafael OC; Lazzaro R; Hasanovic A
Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
[TBL] [Abstract][Full Text] [Related]
14. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines.
Girard N; Deshpande C; Azzoli CG; Rusch VW; Travis WD; Ladanyi M; Pao W
Chest; 2010 Jan; 137(1):46-52. PubMed ID: 19376842
[TBL] [Abstract][Full Text] [Related]
15. Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas.
Eng J; Woo KM; Sima CS; Plodkowski A; Hellmann MD; Chaft JE; Kris MG; Arcila ME; Ladanyi M; Drilon A
J Thorac Oncol; 2015 Dec; 10(12):1713-9. PubMed ID: 26334752
[TBL] [Abstract][Full Text] [Related]
16. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the proliferative activity in lung adenocarcinomas with specific driver mutations.
Kriegsmann M; Harms A; Kazdal D; Fischer S; Stenzinger A; Leichsenring J; Penzel R; Longuespée R; Kriegsmann K; Muley T; Safi S; Warth A
Pathol Res Pract; 2018 Mar; 214(3):408-416. PubMed ID: 29487011
[TBL] [Abstract][Full Text] [Related]
18. Lesions in patients with multifocal adenocarcinoma are more frequently in the right upper lobes.
Kaneda H; Uemura Y; Nakano T; Taniguchi Y; Saito T; Konobu T; Saito Y
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):627-32. PubMed ID: 22733594
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of lung adenocarcinoma with KRAS mutations.
Kakegawa S; Shimizu K; Sugano M; Miyamae Y; Kaira K; Araki T; Nakano T; Kamiyoshihara M; Kawashima O; Takeyoshi I
Cancer; 2011 Sep; 117(18):4257-66. PubMed ID: 21387273
[TBL] [Abstract][Full Text] [Related]
20. Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas.
Yu HA; Sima CS; Hellmann MD; Naidoo J; Busby N; Rodriguez K; Riely GJ; Kris MG
Cancer; 2015 Jun; 121(12):2078-82. PubMed ID: 25781862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]